Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 4Urinary Bladder Neoplasms 1Nephrotic Syndrome 1Neoplasms 1Neoplasm Metastasis 1Locally Advanced Bladder Cancer 1Kidney Diseases 1Gastrointestinal Diseases 1Familial Mediterranean Fever 1Carcinoma, Non-Small-Cell Lung 1Arthritis, Rheumatoid 1Amyloidosis 1

Interventions

Gemcitabine 157Cisplatin 117pembrolizumab 81Cystectomy 46Nivolumab 42Carboplatin 42Paclitaxel 41Mitomycin 41Docetaxel 39atezolizumab 33Magnetic Resonance Spectroscopy 33Radiotherapy 31durvalumab 30avelumab 26BCG Vaccine 26Specimen Handling 25Cystoscopy 24enfortumab vedotin 23Doxorubicin 23Fluorouracil 20Methotrexate 17Vinblastine 16Standard of Care 15Ipilimumab 14Filgrastim 145-aminolevulinic acid hexyl ester 14Transurethral Resection of Bladder 13Surgical Procedures, Operative 13Sunitinib 13Biopsy 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Urinary Bladder Neoplasms × Pharmaceutical Preparations × Genitourinary × Clear all
NCT00526656 2019-04-16

Sunitinib in Treating Patients With Locally Advanced Bladder Cancer

Case Comprehensive Cancer Center

Phase 2 Completed
9 enrolled 5 charts
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡